Use of chemotherapy at the end of life in a Portuguese oncology center

Supportive Care in Cancer

Volumn 16, Issue 4, 2008, Pages 321-327

  Gonçalves, José Ferraz ^a   Goyanes, Carmen ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

Author keywords

Advanced cancer; Chemotherapy; End of life; Palliative care; Symptom Control

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; COMORBIDITY; DEATH; FEMALE; HUMAN; KIDNEY CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SOLID TUMOR; TERMINAL CARE;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASMS; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; PORTUGAL; REGISTRIES; TERMINAL CARE;

EID: 43449110962     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0316-x     Document Type: Article

References (18)

1. Aragon-Ching JB, Cohn JB, Cohn A (2003) Chemotherapy at the end of life. Proc Am Soc Clin Oncol 22(abst 3119)
2. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS (2003) Chemotherapy use among Medicaire beneficiaries at the end of life. Ann Intern Med 138:639-643
3. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC (2004) Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol 22:315-321
4. Matsuyama R, Reddy S, Smith TJ (2006) Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24:3490-3496
5. Earle CC, Venditti LN, Neumann PJ, Gelber RD, Weinstein MC, Potosky AL, Weeks JC (2000) Who gets chemotherapy for metastatic lung cancer. Chest 117:1239-1246
6. Harlan LC, Clegg LX, Trimble EL (2003) Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol 21:3488-3494
7. Hurria A, Naeim A, Elkin E, Limaye S, Grover A, Hudis C, Pearce C, Robson M (2007) Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists. Crit Rev Oncol Hematol 61:255-260
8. Doyle C, Crump M, Pintilie M, Oza AM (2001) Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. J Clin Oncol 19:1266-1274
9. Slevin ML, Stubbs I, Plant HJ et al (1990) Attitudes to chemotherapy: comparative views of patients with cancer with those of doctors, nurses, and general public. BMJ 300:1458-1460
10. Yellen SB, Cella DF (1995) Someone to live for: social well-being, parenthood status and decision-making in oncology. J Clin Oncol 13:1255-1264
11. Jirillo A, Boscaro M, Passeto LM, Monfardini S (2005) Chemotherapy at the end of life: an open question. Tumori 91:104-105
12. Glare P, Virik K, Jones M et al (2003) A systematic review of physicians' predictions in terminally ill cancer patients. BMJ 327:195-200
13. Ellis PA, Smith IE, Hardy JR, Nicolson MC, Talbot DC, Ashley SE, Priest K (1995) Symptom relief with MVPP (mitomycin C, vinblastine and cisplatina) chemotherapy in advanced non-small-cell lung cancer. BJC 71:366-370
14. Cullen MH, Billingham LJ, Woodroffe CM et al (1999) Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17:3188-3194
15. Cunningham D, Pyrhönen S, James RD et al (1998) Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413-1418
16. Burris HA, Moore MJ, Andersen MJ et al (1997) Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413
17. Wan GJ, Counte MA, Cella DF (1997) The influence of personal expectations on cancer patients' report of health-related quality of life. Psycho-Oncol 6:1-11
18. Graffar M (1956) Une méthode de Classification Social d'échantillon de la population. Courier 6:455-459